Autophagy is an evolutionarily conserved catabolic process involved in several physiological and pathological processes 1, 2 . Although primarily cytoprotective, autophagy can also contribute to cell death; it is thus important to understand what distinguishes the life or death decision in autophagic cells 3 . Here we report that induction of autophagy is coupled to reduction of histone H4 lysine 16 acetylation (H4K16ac) through downregulation of the histone acetyltransferase hMOF (also called KAT8 or MYST1), and demonstrate that this histone modification regulates the outcome of autophagy. At a genome-wide level, we find that H4K16 deacetylation is associated predominantly with the downregulation of autophagy-related genes. Antagonizing H4K16ac downregulation upon autophagy induction results in the promotion of cell death. Our findings establish that alteration in a specific histone post-translational modification during autophagy affects the transcriptional regulation of autophagyrelated genes and initiates a regulatory feedback loop, which serves as a key determinant of survival versus death responses upon autophagy induction.
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Autophagy is a catabolic process that results in the autophagosomedependent lysosomal degradation of bulk cytoplasmic contents, abnormal protein aggregates and excess or damaged organelles 1, 2 . This process involves a series of dynamic membrane-rearrangements mediated by a core set of autophagy-related (ATG) proteins 4 . Although autophagy is primarily a protective process for the cell, it can also play a role in cell death 3 ; however, it is not clear what distinguishes the life or death decision 5 . Protein acetylation, in particular acetylation of ULK1 and ATG proteins, has emerged as a regulator of autophagy [6] [7] [8] [9] . Accumulating evidence has established sirtuin 1 (SIRT1), a NAD 1 -dependent deacetylase, as a player in this process 7, 10 . However, SIRT1 is not always required for autophagy to occur. Indeed, although SIRT1 overexpression is sufficient to increase the basal level of autophagy and is required for starvation-induced autophagy, it is not necessary for rapamycininduced autophagy 7, 11 . SIRT1 has a wide range of non-histone targets, but lysine 16 on histone H4 (H4K16) is its primary histone target 12, 13 . The histone acetyltransferase hMOF/KAT8/MYST1 is necessary and sufficient for the bulk of H4K16 acetylation and thereby antagonizes the enzymatic activity of SIRT1 (refs 13-15) . Because SIRT1 has been linked to both autophagy and epigenetic chromatin changes, this encouraged us to investigate the role of covalent histone modifications in autophagy. As SIRT1 preferentially deacetylates H4K16ac 12 , we considered that this histone modification could be altered upon autophagy induction.
We induced autophagy in mouse embryonic fibroblast (MEF) cells by amino-acid starvation and observed a decrease in acetylation of H4K16 (Fig. 1a) . To investigate whether the observed effect on H4K16ac was linked to the role of SIRT1 during starvation-induced autophagy, or if the deacetylation of H4K16 is a general feature of the autophagic process, treatments with rapamycin or Torin 1, respectively allosteric and catalytic inhibitors of the kinase mechanistic target of rapamycin (MTOR), were used to induce SIRT1-independent autophagy ( Supplementary Figs 2a  and 3a) . The global amount of H4K16ac was robustly reduced in MEF cells after those treatments (Fig. 1b and Supplementary Fig. 4a ). Interestingly, in the sirt1 null MEF cells, both rapamycin and Torin 1 treatments, but not amino-acid starvation, induced the downregulation of H4K16ac, confirming that SIRT1 is not required for the repression of this histone modification ( Fig. 1c and Supplementary Figs 2b and 4b) .
The downregulation of H4K16ac upon autophagy induction occurred in various human cancer cell types, namely U1810, HeLa and U2OS cells (Fig. 1d-e and Supplementary Fig. 4c, d ) and was even found to occur in yeast ( Supplementary Fig. 5 ). Rapamycin treatment did not affect total histone H4 amounts ( Supplementary Fig. 6 ). The changes in H4K16 acetylation status were linked to the occurrence of autophagy as established by an increased lipidation of the autophagic marker LC3, resulting in an increased ratio of the lipidated form (LC3-II) to the unlipidated form (LC3-I), referred to later as LC3 conversion (Fig. 1a-d and Supplementary Fig. 3a, b) . Similarly, in yeast this treatment resulted in increased lipidation of Atg8 (yeast homologue of LC3), and both cleavage and vacuolar localization of green fluorescent protein (GFP)-tagged Atg8 ( Supplementary Fig. 7a-c) .
Dynamic histone modifications play a pivotal role in cell regulatory events 16 and the H4K16 residue is of particular interest, as its acetylation influences higher-order chromatin structure 17 and plays an important role in transcription 18 . Chromatin immunoprecipitation targeting H4K16ac, followed by high-throughput sequencing (ChIP-seq) was performed to investigate the genome-wide occurrence of this histone mark in U1810 cells undergoing autophagy (Fig. 2a) . H4K16ac ChIPseq data analysis showed 3,422 called peaks in untreated U1810 cells, which subsequently showed reduced H4K16ac occupancy after 8 h rapamycin treatment. To gain insight into the role of this induced H4K16 deacetylation in the regulation of gene expression during autophagy, we performed a global run-on-sequencing (GRO-seq) assay 19, 20 to generate a genome-wide view of the location, orientation and density of nascent transcripts engaged by RNA polymerases at high resolution in rapamycin-treated compared with untreated U1810 cells ( Fig. 2b and Supplementary Fig. 8a ). This approach unveiled a significant alteration of the U1810 transcriptome with the identification of 1,622 significantly (fold change . 1.5 or , 0.75 and P , 0.001) up-or downregulated genes (Fig. 2b, c and Supplementary Fig. 8a) . A large fraction of the identified genes (141 genes; 8.7%) were related to autophagy ( Fig. 2c and Supplementary Fig. 8b ). There is an overall coincidence across the autophagy-related genes between the alteration of the GRO-seq signal and the absence of H4K16 acetylation. Indeed, 55 genes, that is 39% of the autophagy-related genes (including genes belonging to the autophagic core machinery) identified by GRO-seq analysis, showed reduced H4K16ac tag counts upon rapamycin treatment ( Fig. 2c and Supplementary Fig. 9a , b).
To provide further evidence that the downregulation of H4K16ac during autophagy is part of a specific program, three extra histone modifications were examined, namely H3K4me3, H4K12ac and H4K8ac. In fact, whereas H4K16ac and H3K4me3 are known to be associated histone marks [21] [22] [23] , K8 and K12 acetylation amounts on histone H4 are reported to be independent of H4K16 acetylation 13, 24 .
In agreement with the established molecular link between H4K16ac and H3K4me3, rapamycin-induced autophagy was associated with a reduction in H3K4me3 ( Supplementary Fig. 10a , b), whereas H4K12ac and H4K18ac were left unaffected ( Supplementary Fig. 10c ). The joint downregulation of the H4K16ac and the H3K4me3 histone modifications was also observed in wild-type (WT) yeast, but not atg1D, atg5D and atg7D autophagy-deficient yeast or Sas2-overexpressing yeast (Supplementary 10d). Collectively, these genome-wide deep-sequencing analyses indicate that the observed deacetylation of H4K16 during autophagy results in transcriptional regulation of autophagy-related genes.
Because MTOR is involved in a wide variety of signalling pathways, treating cells with rapamycin or Torin 1 could cause the observed epigenetic changes by mechanisms unrelated to autophagy. To exclude this possibility, we tested the effect of rapamycin on the H4K16ac histone modification in atg5-and atg7-deficient MEF cells. These genes encode two ATG proteins that are essential for the canonical autophagy pathway (Fig. 1b, lower panels) . Treatment of autophagydeficient cells, namely atg7 2/2 or atg5 2/2 MEFs, with rapamycin did not lead to a similar degree of downregulation of H4K16ac (Fig. 1b,  upper panels) . Identical effects were observed in yeast ( Supplementary  Fig. 5) .
Thus, the process of autophagy, independent of whether its induction required a SIRT1-dependent signalling pathway, was associated with deacetylation of H4K16. Collectively, these data suggest that alteration in another histone-modifying enzyme should be responsible for the observed modification in the acetylation status of H4K16. This observation prompted us to examine the status of hMOF during autophagy. Interestingly, although SIRT1 expression was not significantly altered upon rapamycin treatment ( Supplementary Fig. 11a ), hMOF expression was effectively downregulated in mammalian cells (Fig. 3a, b and Supplementary Figs 3a-c and 11a). Similarly, robust downregulation of hMOF expression was observed upon Torin 1 treatment or under amino-acid starvation ( Supplementary Fig. 3a-d) . Remarkably, the observed downregulation of hMOF upon rapamycin, Torin 1 or starvation treatment was abrogated when cells were cotreated with inhibitors of autophagy such as chloroquine (CQ), or 3-methyladenine (3MA) ( Supplementary Fig. 3a-c) . In yeast cells engineered to express an haemagglutinin (HA)-tagged version of the yeast homologue of hMOF, Sas2, rapamycin treatment induced a nearly complete loss of the HA signal within 3 h (Fig. 3g) . Overexpression of Sas2 repressed the downregulation of H4K16ac upon rapamycin treatment in yeast cells (Fig. 3h) . Altogether, these results showed that the downregulation of hMOF is part of the autophagy program.
The observed pronounced changes in amounts of H4K16 acetylation and associated transcriptional gene regulation suggested that there LETTER RESEARCH may be a functional role for this epigenetic change during autophagy. It has only recently become clear how histone modifications can play a regulatory role in apoptosis and how they can influence the decision between life and death (reviewed in ref. 25) . A similar regulatory role for histone modifications could be present during autophagy. Shifting the equilibrium of hMOF and SIRT1 expression in favour of SIRT1 leads to a decrease in acetylation of H4K16 (ref. 13) . Treatment with valproic acid (VPA) increased the acetylation status of H4K16 (Fig. 3c and Supplementary Fig. 11b-d) by reducing SIRT1 amounts 13 . Treatment with VPA was not only able to reverse rapamycin-induced downregulation of the H4K16ac histone modification (Fig. 3c) , but also promoted LC3 conversion and turnover ( Fig. 3d and Supplementary  Fig. 11e ). Administration of chloroquine to inhibit lysosomal activity enhanced the rapamycin-induced increase in LC3-II amounts. Cotreatment with VPA led to a further increase in the LC3-II amounts, confirming the increased autophagic flux in those cells (Fig. 3e and Supplementary Fig. 11f ). Combined treatment with bafilomycin A 1 (BafA), which prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes, led to similar results ( Supplementary Fig. 12 ). The increase in the autophagic flux in those cells was further confirmed, making use of a tandem reporter construct, mRFP-GFP-LC3 (ref. 26) (Fig. 4a, b and Supplementary  Figs 13a, 14 and 15 ). Rapamycin treatment resulted in an increase of yellow-colour-labelled LC3 puncta in U1810 and HeLa cells. In contrast, a remarkable increase in punctate red fluorescent signals was detected upon VPA and rapamycin treatment in both cell types (Fig. 4a, b and Supplementary Figs 13a and 14) . Similarly, hMOF overexpression in HeLa and U1810 cells correlated with increased autophagic flux upon rapamycin treatment, as illustrated by LC3 immunoblotting (Fig. 3b, f) and the mRFP-GFP-LC3 autophagic flux assay ( Supplementary Fig. 15 ).
We extended our investigation to the analysis of cell death. We observed a significant increase in cell death in human-derived cell lines co-treated with rapamycin, and VPA or the SIRT1-specific inhibitor Ex527 (ref. 13) , as demonstrated by the appearance of condensed or fragmented nuclei (Fig. 4c, f and Supplementary Figs 13b, e and 16a, b) . These results were further confirmed by fluorescence-activated cell sorting analysis of the appearance of a sub-G1 hypodiploid DNA peak ( Supplementary Fig. 17a, b) . In agreement with the observed effect of SIRT1 chemical inhibitors on the outcome of autophagy, we observed a significant increase in cell death in HeLa or U1810 cells upon SIRT1-knockdown and rapamycin treatment ( Fig. 4e and Supplementary  Fig. 13d ). To investigate whether the observed cell death upon abrogation of H4K16 deacetylation after rapamycin treatment was a consequence of autophagy induction, we performed an extra set of experiments with CQ, BafA and 3MA, which inhibit different steps in the autophagic pathway. We noted that co-treatment with these inhibitors of autophagy was able to abrogate both rapamycin 1 VPA-and rapamycin 1 Ex527-induced cell death in human cancer cells (Fig. 4d, g, h and Supplementary Figs 13c and 16c-e) . Knockdown of ATG7 expression in mammalian cells prevented rapamycin 1 VPA-induced cell death and thus further strengthens the conclusion about an autophagy-mediated cell death (Supplementary Fig. 18 ). It is worth noting that the increased cell death upon VPA addition was not limited to rapamycin-induced autophagy, and was observed in amino-acid-starved HeLa cells (Fig. 4i, j) . Furthermore, we investigated the link between hMOF activity and the outcome of autophagy. In agreement with the discovery that the perturbation of H4K16 acetylation status regulates the outcome of autophagy, we observed a significant increase in cell death in hMOF-overexpressing HeLa or U1810 cells upon rapamycin treatment, mimicking the effect of VPA/rapamycin co-treatment ( Fig. 4f and Supplementary Fig. 13e ). Collectively, these data indicate that the downregulation of hMOF, the associated reduction in H4K16 acetylation level and transcriptional regulation of autophagy-related genes are required for the proper progression of the autophagic process, and that disturbance of this epigenetic program results in cell death.
In conclusion, until now, nuclear events have not been considered of primary importance for autophagy, as enucleated cells are still able to accumulate GFP-LC3 puncta in response to autophagic stimuli 
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and covalent histone H4K16 modifications with altered gene expression, including the regulation of key genes in the autophagy program. Our findings imply a molecular histone switch, where the balancing effects of hMOF and SIRT1 on H4K16 acetylation regulate autophagy ( Supplementary Fig. 1 ). Our results do not oppose the findings about functionality of the autophagic process in enucleated cells, but add a new feedback regulatory network influencing the outcome of autophagy with respect to cell death/survival. The identification of tightly regulated histone modifications associated with the autophagic process offers an attractive conceptual framework to understand the short-term transcriptional response to stimuli eliciting autophagy, as well as constituting a potential aspect of long-term responses to autophagy.
METHODS SUMMARY
Antibodies and reagents used in this study are listed in Supplementary Tables 1  and 2 . ON-TARGET plus SMARTpools short interfering RNAs (siRNAs) were purchased from Dharmacon (Supplementary Table 3 ). Experiments were performed on U1810, U2OS and HeLa human cancer cells and wild-type, atg5
2/2 and sirt1 2/2 mouse embryonic fibroblasts as well as wild-type, atg1D, atg5D and atg7D SEY6210 yeast cells. Histone protein extracts, total protein extracts and immunoblotting were performed as reported previously 13, 27, 28 . ChIPseq and GRO-seq analyses were executed as described elsewhere 19, 20 . MEF cell line was a gift from M. Komatsu 30 and the sirt1 2/2 MEF cell line was a gift from X. Li. SEY6210 wild-type, atg1D, atg5D and atg7D yeast cells were grown as described previously 31 . Reagents used in this study are listed in Supplementary  Table 2 . Plasmids encoding HA-human MOF, Flag-human SIRT1 and mRFP-GFP-LC3 were gifts from R. G. Roeder, L. Guarente and G. Mc Inerney, respectively. Transfection of cells used lipofectamine and lipofectamine reagent in HeLa cells and X-tremeGENE HP DNA transfection reagent in U1810 cells. Histone extracts and immunoblotting. Histone protein extracts were performed as described elsewhere 13, 27 using TCA precipitation and H 2 SO 4 extraction or using the Histone Purification Mini Kit (Active Motif). Total protein extracts and immunoblotting were performed as reported previously 28 . GAPDH, b-actin, histone 3 (H3) and phosphoglycerate kinase 1 (Pgk1) were used as standards for equal loading of protein. Antibodies used in this study are listed in Supplementary  Table 1 . Densitometry was done using ImageJ. Yeast procedures. The GFP-Atg8 processing assay and fluorescence microscopy were performed as described previously 32 . If not stated otherwise, all experiments were performed at 1 h treatment. Immunofluorescence and confocal microscopy. For confocal microscopy analysis, the adherent mammalian cells were grown on coverslips. Paraformaldehydefixed cells were blocked in HEPES, 3% bovine serum albumin, 0.3% Triton X-100 and incubated with primary (4 uC, overnight) and secondary (room temperature, 1 h) antibodies. Samples were mounted with Vectashield (Vector Laboratories) and analysed with Zeiss 510 META confocal laser scanning microscopy (Zeiss) 28 . Evaluation of autophagic flux. Autophagy was assessed following the 'Guidelines for the use and interpretation of assays for monitoring autophagy' 29 . To monitor the autophagic flux, a tandem reporter construct mRFP-GFP-LC3 was used 26 . The green fluorescence of this tandem reporter is attenuated in the acidic pH lysosomal environment, whereas the mRFP is not. Therefore, the green fluorescent component of the composite yellow fluorescence from this mRFP-GFP-LC3 reporter is lost upon autophagosome fusion with a lysosome, whereas the red fluorescence remains detectable. Thus this probe allows distinction between autophagosomes (GFP1/RFP1 yellow puncta) and autolysosomes (GFP2/RFP1 red puncta). At 24 h after plating, the cells were transfected with the mRFP-GFP-LC3 plasmid, alone or in combination with SIRT1 siRNA, control siRNA or hMOF plasmid. ON-TARGET plus SMARTpools siRNAs were purchased from Dharmacon (Supplementary Table 3 ). The next day, cells were treated for an extra 24 h with the indicated compound(s). Cells were then fixed using 4% paraformaldehyde, and autophagy was determined by quantification of the number of cells with LC3-positive organelles, counting at least 100 cells in triplicate per condition. The presence of autophagic vacuoles expressing endogenous LC3 was also assessed. Cell death quantification. After treatment, cells were fixed in 4% paraformaldehyde, collected and cytospins were prepared. Subsequently, DNA was stained with Hoechst 33342 (0.1 mg ml
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; Molecular Probes/Invitrogen). The number of dying cells was measured quantitatively by assessing the percentage of cells with fragmented, damaged or condensed nuclei. Fluorescence-activated cell sorting analysis. Quantification of PI (Sigma) and TMRE (Molecular Probes/Invitrogen) staining was performed with a FACSCalibur flow cytometer (Becton Dickinson) using standard procedures 28 . ChIP-sequencing. For ChIP-seq analysis, 5 mg of chromatin was used in two separate immunoprecipitations and combined in one elution for each condition. Subsequently, the DNA sequencing library was made using a kit from Illumina (catalogue number 1003473) except that Illumina TruSeq adaptors (to enable multiplexing) were used. The library was analysed by Solexa/Illumina Hi-seq. After pre-filtering the raw data by removing sequenced adapters and low quality reads, the sequence tags were aligned to the human genome (assembly hg19) with the Bowtie alignment tool 33 . To avoid any PCR-generated spikes we allowed only one read per chromosomal position, thus eliminating PCR bias. From the filtered raw data, 8 million unique reads per sample were used for peak detection. Peak detection was performed using the CisGenome program 34 with a two-sample analysis where sequenced input (1%) was used as a negative control. Peaks were called with a window statistic cut-off of 3 and a log 2 -fold change of 2. Using the defined chromosomal peak regions from the no-treatment condition, the number of tags were counted in the corresponding rapamycin-treated sample and heat maps were generated using Java Treeview 35 
